Novo Nordisk A/S Common Stock (NY:NVO)Price and VolumeDetailed Quote
Top NewsMore News
Performance
52-Week Range
41.5% below 52-week high
37.53
35.1252W Low
64.1652W High
1 Week
3.2% below 1-week high
36.841W Low
38.771W High
Novo Nordisk A/S Common Stock (NVO) traded between $35.12 and $64.16 over the past 52 weeks and last traded at $37.53, 41.5% below its 52-week high. Over the past week it ranged between $36.84 and $38.77.
Past 12 Months
-1.0%
-16.9%
-24.4%
+1.7%
-28.4%
-37.1%
1W
-$0.38
1M
-$7.63
3M
-$12.11
6M
+$0.62
YTD
-$14.86
1Y
-$22.12
NVO was -37.1% over the past year, +1.7% over six months, -28.4% year to date, -1.0% in the last week.
12 Months vs Market
NVO
DIA
SPY
QQQ
IWM
Over the past 12 months NVO returned -37.1% versus DIA (Dow) +10.2%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +25.0% and IWM (Russell 2000) +14.0%.
Volume & Liquidity
0.01× 3-mo avg
Today 67,791
3-mo avg 12.5M
1W
1M
3M
6M
YTD
1Y
NVO most recently traded 67,791 shares against a 3-month average daily volume of 12.5M. More NewsRead More
Better High-Yield Dividend Stock: Pfizer or Novo Nordisk? ↗
October 04, 2026
Via The Motley Fool
Via The Motley Fool
Topics
Intellectual Property
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy ↗
September 30, 2026
Via The Motley Fool
Topics
Initial Public Offering
3 Emerging Biotech Stocks With Significant Upside Potential ↗
September 30, 2026
Via MarketBeat
Topics
Intellectual Property
4 Stocks That Could Split Next—and Why Investors Are Watching ↗
September 30, 2026
Via MarketBeat
Topics
Artificial Intelligence
Novo Nordisk Gives Uninspiring Outlook ↗
September 29, 2026
Via The Motley Fool
Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip ↗
September 29, 2026
Via The Motley Fool
Eli Lilly Just Announced Game-Changing News ↗
September 28, 2026
Via The Motley Fool
Here's Where Wall Street Analysts See Eli Lilly's Share Price Going ↗
September 26, 2026
Via The Motley Fool
Via The Motley Fool
Topics
Intellectual Property
Could This Be Novo Nordisk’s Next Billion-Dollar Weight-Loss Product? ↗
September 25, 2026
Via The Motley Fool
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? ↗
September 24, 2026
Via The Motley Fool
Topics
Intellectual Property
Viking's Obesity Edge May Be Staying Power, Not Weight Loss ↗
September 23, 2026
Via MarketBeat
Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up? ↗
September 23, 2026
Via MarketBeat
Why Viking Therapeutics Stock Skyrocketed on Tuesday ↗
September 23, 2026
Via The Motley Fool
Via The Motley Fool
Novo Nordisk Targets Five Multi-Blockbusters by 2030 as Oral Wegovy Gains Traction ↗
September 21, 2026
Via MarketBeat
Why Novo Nordisk Stock Just Crashed ↗
September 21, 2026
Via The Motley Fool
Frequently Asked QuestionsIs Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 37.53
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 10/06/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>